Showing results (1851-1860 of 2,040) with videos related to
Sort By:
Pageof 204
Cell Research|January 2, 2014
High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cellsGang Chang, Shuai Gao, Xinfeng Hou, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2024
Neurotransmitters: Impressive regulators of tumor progressionYumei Yang, Lei Sun, Xuerou Liu, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Quinolinic acid metabolism may mitigate AKI to CKD transitionMarie Christelle Saade, Afaf Saliba, Amanda J Clark, et al.Chinese Medical Journal|January 31, 2015
Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label studySong Tan, Rui-Hao Wang, Hui-Xia Niu, et al.Journal of Digestive Diseases|June 23, 2025
An Open-Label Randomized Controlled Non-Inferiority Trial of Arginine Glutamate Injection for the Treatment of Mild Hepatic EncephalopathyHai Bo Zhang, Huai Bin Zou, Yun Yi Gao, et al.Frontiers in Plant Science|February 5, 2024
Differential gene expression and potential regulatory network of fatty acid biosynthesis during fruit and leaf development in yellowhorn (Xanthoceras sorbifolium), an oil-producing tree with significant deployment valuesTian-Le Shi, Hai-Yao Ma, Xinrui Wang, et al.Japanese Journal of Infectious Diseases|May 26, 2012
A prospective comparison of the epidemiological and clinical characteristics of pandemic (H1N1) 2009 influenza A virus and seasonal influenza A viruses in Guangzhou, South China in 2009Zi-feng Yang, Yang-qing Zhan, Rong-chang Chen, et al.General Hospital Psychiatry|December 4, 2015
Smoking and its associations with sociodemographic and clinical characteristics and quality of life in patients with schizophrenia treated in primary care in ChinaYan Li, Cai-Lan Hou, Xin-Rong Ma, et al.Acta Pharmaceutica Sinica. B|July 15, 2026
A novel NAMPT activator ameliorates obesity by repressing ACSL1-dependent lipid synthesisZhi Jiang, Yi-Xian Li, Dan-Dan Zhao, et al.Nature Medicine|October 13, 2021
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan-Fung Yuen, Jeong Heo, Jeong-Won Jang, et al.Pageof 204